CANNORDIC India Ltd., a CS MEDICA Subsidiary, Signs Letter of Intent with the Pharmaceutical Company Zuventus Healthcare to Launch CANNASEN® in India
The Partnership Projects Up to €15 Million Revenue from Innovative CBD-infused Medical Devices by Year Three Post-Registration.CANNORDIC India Ltd., under the umbrella of CS MEDICA Group, has signed a Letter of Intent (LOI) with Zuventus Healthcare Ltd., a premier pharmaceutical company in India. This agreement marks the initial engagement towards establishing a preferred partnership for distributing and marketing the CANNASEN® brand within the medical device category across India. The partnership will focus on addressing autoimmune diseases and stress-related disorders. The